The level of netrin-1 is decreased in newly diagnosed type 2 diabetes mellitus patients
- PMID: 27255377
- PMCID: PMC4890509
- DOI: 10.1186/s12902-016-0112-z
The level of netrin-1 is decreased in newly diagnosed type 2 diabetes mellitus patients
Abstract
Background: Pancreatic β-cell dysfunction resulting from inflammation has been recognized to contribute to type 2 diabetes mellitus (T2DM). Netrin-1 is a new indicator of subclinical inflammation and it has a role in β-cell apoptosis. This study evaluated the level of netrin-1 in newly diagnosed T2DM patients and explored whether netrin-1 is a reliable marker or a key factor in the development of T2DM.
Methods: Netrin-1 level was determined using a commercially available human enzyme-linked immune sorbent assay (ELISA) kit. The homeostasis model assessment of insulin resistance (HOMA-IR) was used as an index to measure insulin resistance. The sample consisted of 30 patients with newly diagnosed T2DM who had a glycosylated hemoglobin (HbA1c) level ranging from 7.5 % (58 mmol/mol) to 10.5 % (91 mmol/mol). The control group consisted of 26 healthy individuals matched for age and body mass index.
Results: The netrin-1 level of T2DM patients was significantly lower than that of healthy controls (p < 0.01). Logistic regression analysis showed that the level of netrin-1 was negatively correlated with HOMA-IR, fasting blood glucose, postprandial blood glucose, fasting insulin and HbA1c.
Conclusions: Plasma netrin-1 levels were decreased in patients with newly diagnosed T2DM, and the levels of netrin-1 were negatively associated with IR and glucose homeostasis. Future studies on the precise mechanism will offer new insights into the prevention and treatment of T2DM.
Keywords: Inflammation; Insulin resistance; Mechanism; Netrin-1; Type 2 diabetes mellitus.
Figures
Similar articles
-
Circulating levels of cortistatin are correlated with metabolic parameters in patients with newly diagnosed type 2 diabetes mellitus.Peptides. 2017 Aug;94:86-90. doi: 10.1016/j.peptides.2017.05.008. Epub 2017 May 17. Peptides. 2017. PMID: 28526556
-
[Association between both resistin, visfatin and insulin resistance as well as β cell function in the first-degree relatives of type 2 diabetes mellitus].Zhonghua Liu Xing Bing Xue Za Zhi. 2010 Dec;31(12):1393-6. Zhonghua Liu Xing Bing Xue Za Zhi. 2010. PMID: 21223671 Chinese.
-
[The relationship between oxidative stress and endothelial progenitor cells count in the first-degree relatives of diabetes mellitus].Zhonghua Nei Ke Za Zhi. 2012 Mar;51(3):197-200. Zhonghua Nei Ke Za Zhi. 2012. PMID: 22781892 Chinese.
-
Urinary and circulatory netrin-1 as biomarker in diabetes and its related complications: a systematic review and meta-analysis.Endocrine. 2024 May;84(2):328-344. doi: 10.1007/s12020-023-03598-y. Epub 2023 Nov 23. Endocrine. 2024. PMID: 37996774
-
Of rodents and men: species-specific glucose regulation and type 2 diabetes research.ALTEX. 2014;31(2):157-76. doi: 10.14573/altex.1309231. ALTEX. 2014. PMID: 24270692 Review.
Cited by
-
Decreased Netrin-1 in Mild Cognitive Impairment and Alzheimer's Disease Patients.Front Aging Neurosci. 2022 Feb 16;13:762649. doi: 10.3389/fnagi.2021.762649. eCollection 2021. Front Aging Neurosci. 2022. PMID: 35250531 Free PMC article.
-
Axon Guidance Molecules in the Islets of Langerhans.Front Endocrinol (Lausanne). 2022 Apr 14;13:869780. doi: 10.3389/fendo.2022.869780. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35498433 Free PMC article. Review.
-
Netrin-1: A Modulator of Macrophage Driven Acute and Chronic Inflammation.Int J Mol Sci. 2021 Dec 27;23(1):275. doi: 10.3390/ijms23010275. Int J Mol Sci. 2021. PMID: 35008701 Free PMC article. Review.
-
Downregulation of the Netrin-1 Receptor UNC5b Underlies Increased Placental Angiogenesis in Human Gestational Diabetes Mellitus.Int J Mol Sci. 2019 Mar 20;20(6):1408. doi: 10.3390/ijms20061408. Int J Mol Sci. 2019. PMID: 30897795 Free PMC article.
-
Netrin-1 in Atherosclerosis: Relationship between Human Macrophage Intracellular Levels and In Vivo Plaque Morphology.Biomedicines. 2021 Feb 8;9(2):168. doi: 10.3390/biomedicines9020168. Biomedicines. 2021. PMID: 33567662 Free PMC article.
References
-
- Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B, American Diabetes A. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009;32(1):193–203. - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical